GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Total Stockholders Equity

Belluscura (FRA:9VQ) Total Stockholders Equity : €23.26 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Total Stockholders Equity?

Belluscura's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €23.26 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Belluscura's Book Value per Share for the quarter that ended in Jun. 2023 was €0.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Belluscura's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.00.


Belluscura Total Stockholders Equity Historical Data

The historical data trend for Belluscura's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Total Stockholders Equity Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Total Stockholders Equity
2.02 3.36 3.84 21.84 19.21

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 23.25 21.84 22.51 19.21 23.26

Belluscura  (FRA:9VQ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Belluscura's Book Value per Share for the quarter that ended in Jun. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Belluscura's Debt-to-Equity for the quarter that ended in Jun. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Belluscura Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Belluscura's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines